Business Standard

Disrupting healthcare: Long-dreaded threat to drug middlemen draws close

The prospect of Amazon entering the health-care industry has had retailers, drugmakers and insurance companies looking over their shoulders since last fall

The phenomenal rise of Jeff Bezos - a 'mysterious' corporate titan
Premium

Jeff Bezos

Robert Langreth & Zachary Tracer | Bloomberg
A day that prescription-drug middlemen had long feared finally arrived.

The industry awoke to the news Tuesday that Amazon.com Inc was joining with Berkshire Hathaway Inc and JPMorgan Chase & Co to form a new health-care business, in an attempt by three of the world’s best-known companies to contain the spiraling cost of keeping their US workers healthy.

Other groups of big employers have tried to improve worker health care in the past, but none have dethroned the pharmacy-benefit managers who drug companies and some lawmakers claim aren’t transparent about the pricing deals they strike on behalf of health plans,

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 31 2018 | 8:42 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com